Yahoo Web Search

Sign In

Search results

  1. careers.gene.comCareers at Genentech

    ONE PURPOSE. ONE PROMISE. Get tailored job recommendations based on your interests. Get Started. WHY GENENTECH. We’re passionate about delivering on Our Promise to improve the lives of patients and create healthier communities for all.

    • BENEFITS

      Our comprehensive benefits are built around your life, so...

    • MILITARY HIRING

      Make an impact and continue your career of service.

    • BROWSE JOBS

      Search results. Find available job openings at Genentech

    • JOIN TALENT COMMUNITY

      Interested in working with Genentech? Join and become part...

  2. ph.linkedin.com › company › genentechGenentech | LinkedIn - LinkedIn Philippines

    Genentech | 745,057 (na) tagasubaybay sa LinkedIn. About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why...

  3. www.gene.comGenentech

    Genentech's legacy and future aspirations are built on the belief that the boundaries of science are meant to be broken and that we can solve some of the hardest biomedical challenges plaguing humankind. Learn More. Quick Links. Advancing Inclusive Research. Patient Financial Support.

  4. www.gene.com › about-usGenentech: About Us

    Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

  5. en.wikipedia.org › wiki › GenentechGenentech - Wikipedia

    Genentech is a pioneering research-driven biotechnology company that has continued to conduct R&D internally as well as through collaborations. Genentech's research collaborations include: In 2008 Genentech entered into a collaboration with Roche and its subsidiary GlycArt to develop obinutuzumab.

  6. www.gene.com › genentech-to-reintroduce-susvimo-for-peoGenentech: Press Releases | Monday, Jul 8, 2024

    1 day ago · By continuously delivering medicine to the eye through a refillable implant, Susvimo is the first and only approved wet AMD treatment shown to maintain vision with two refills a year. South San Francisco, CA -- July 8, 2024 --. Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the reintroduction of Susvimo ...

  7. www.genengnews.com › gen-edge › genedit-tackles-deliveryGenEdit Tackles "Delivery, Delivery, Delivery" with Up-to-$644M...

    Jan 26, 2024 · GenEdit and Genentech launch an up-to-$644 million collaboration to discover and develop novel nanoparticles capable of delivering the Roche subsidiary’s nucleic acid-based treatments for ...